P/E ratio for Mediclinic International (MEI.JO)
P/E ratio at the end of 2022: 13.6
According to Mediclinic International's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.8378. At the end of 2022 the company had a P/E ratio of 13.6.
P/E ratio history for Mediclinic International from 2016 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 13.6 | -45.49% |
| 2021 | 24.9 | -547.12% |
| 2020 | -5.57 | -51.36% |
| 2019 | -11.5 | 102.7% |
| 2018 | -5.65 | -133.91% |
| 2017 | 16.7 | -30.62% |
| 2016 | 24.0 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.